At home, politicians and the public have castigated Poonawalla and his company, the Serum Institute of India, for raising prices mid-pandemic. Last year, Serum struck a deal with AstraZeneca to produce 1 billion doses of its Oxford-AstraZeneca vaccine, called Covishield in India. Serum pledged between January and March to sell about 1.1 billion vaccine doses in coming months, according to a review of purchase agreements supplied by UNICEF. By the time India largely stopped vaccine exports, Serum had exported only about 60 million doses, about half to Gavi. I may be a global Indian company, but the fact is that we are in India.

Source: bd News24 May 08, 2021 04:52 UTC